🇺🇸 FDA
Patent

US 12116589

Treatment of amyotrophic lateral sclerosis (ALS)

granted A61KA61K31/713A61P

Quick answer

US patent 12116589 (Treatment of amyotrophic lateral sclerosis (ALS)) held by VOYAGER THERAPEUTICS, INC. expires Mon Oct 10 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
VOYAGER THERAPEUTICS, INC.
Grant date
Tue Oct 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 10 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/713, A61P, A61P25/28